A provisional patent application is a lower cost, 12 month placeholder that secures your filing date without formal examination. It never becomes a patent on its own. A non provisional application is the full, examined filing that can actually grant. USPTO fees for a provisional run roughly $65 to $325 depending on entity status, compared with about $1,820, $910, or $364 for a non provisional filed as standard, small, or micro entity respectively. The EU has no provisional application at all. Instead, a first filing at a national patent office or directly with the EPO starts a 12 month priority year under the Paris Convention, during which a later EP filing can claim that same priority date. In both systems, a thin or vague first filing can weaken or void the priority date it was meant to protect.

Sources: USPTO, Provisional Application for Patent, WIPO, Paris Convention.

A US utility patent takes 24 to 27 months on average from filing to grant or abandonment, with the first office action arriving around 20 to 22 months in. One round of office actions closes at 24 to 30 months total, two rounds run 30 to 36 months, and a Request for Continued Examination or appeal can stretch to 40 to 50+ months. Track One prioritized examination targets final disposition within 12 months for an added fee. A European patent (EPO) typically takes 2 to 5 years to grant, even though the EPO's own internal targets are faster, aiming for a search report within 6 months under its Early Certainty programme and examination completed within 12 months of a valid request. The gap comes from applicant response time and, often, multiple rounds of examination. The EPO's PACE programme offers accelerated search and examination at no extra fee.

Sources: USPTO, Patents Pendency Data, EPO.

A US utility patent typically costs $8,000 to $25,000 all in through issuance, including USPTO fees of about $1,820 for standard entities, $910 for small entities, or $364 for micro entities in 2026. A European patent (EPO) typically costs €15,000 to €30,000 through grant, including roughly €6,000 in official EPO fees plus attorney and drafting fees, and that's before validating the granted patent in individual countries, which adds €500 to €3,000 per country, or a single roughly €1,775 Unitary Patent fee for coverage across 18 EU states. Maintenance fees are separate in both systems: US fees are due at 3.5, 7.5, and 11.5 years post grant, while EPO renewal fees are due annually starting in year 3, even before grant. Confirming entity or reduction status correctly before filing is the single biggest cost lever most applicants miss on either side.

Sources: USPTO Fee Schedule, 37 CFR § 1.16, EPO.

A patent application has four core components in both the US and EU: the specification, a full written description of the invention; the claims, the precise legal boundaries of what's protected; drawings, technical figures where necessary to understand the invention; and an abstract, a short summary. Claims are the part that actually gets enforced, so founders who over invest in the specification and under invest in claims are protecting the wrong thing in either jurisdiction. The EU adds one requirement the US doesn't have: you must specify which of the EPO's contracting states you want the eventual patent to cover, and translate the claims into two further EPO official languages (English, French, and German) before grant.

Sources: USPTO, Nonprovisional Patent Application Basics, EPC Article 78, Requirements of a European patent application.

In the US, an office action is the examiner's written response to your application, usually raising objections or rejecting some or all claims based on prior art, with 3 months to respond, extendable to 6 with a fee. Missing the deadline causes the application to go abandoned. In the EU, the equivalent is a Communication under Article 94(3) EPC, an examination report from the EPO, with a standard 4 month deadline extendable through further processing; applications typically go through about two rounds before grant. In both systems, the examiner's citations usually point to genuine prior art, so the response is a negotiation over claim scope rather than a fight to overturn the rejection outright. Narrowing claims strategically, rather than ignoring the objection or over narrowing out of caution, is where experienced counsel earns its fee in either jurisdiction.

Sources: USPTO, Office Actions, EPC Article 94, Examination of the European patent application.

A PCT (Patent Cooperation Treaty) application is a single international filing that reserves your right to seek patent protection in over 150 member countries, without committing to any of them yet. You have up to 30 months from your earliest priority date to enter the national phase in the US through the USPTO, or the regional phase in the EU through the EPO (31 months for EPO entry). It does not grant a single international patent. The USPTO and EPO each examine and grant separately. Entering the EPO regional phase via PCT usually skips a supplementary EPO search if the EPO already acted as the International Searching Authority, which is common for US, Japanese, and Chinese applicants. An International Search Report and Written Opinion produced during the PCT phase give an early read on patentability before national or regional phase costs are committed in either market.

Sources: WIPO, PCT: The International Patent System, USPTO, Patent basics.

As soon as you file in the US, your invention is patent pending. This carries no enforceable rights yet, but it puts competitors on notice and lets you use the term publicly, lasting until grant, abandonment, or, for provisionals, the 12 month expiry. In the EU, filing gives you provisional protection rights once the application publishes, functioning similarly in practice and giving certain rights to compensation for infringement occurring after publication, once the patent eventually grants. Both systems publish the application automatically 18 months after the earliest priority date, making it fully public and searchable, including by competitors, regardless of whether a decision has been reached. From there, the US enters the office action queue and the EU enters search and examination.

Sources: USPTO, Patent Process Overview, EPC Article 67, Rights conferred by a European patent application after publication.